Emergency Medicine Doctors in Huntingdon, PA Accepting Medicare

6 Emergency Medicine doctors found. Showing 1 - 6

Dr. George E Thorpe, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-2290    Fax: 814-643-8334

Dr. Ashish Bagal, MD, PHD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1227 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-2290

Dr. Gary Andrew Herring, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-2290    Fax: 814-643-8813

Ann-marie Cittadino, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-8408    Fax: 814-643-7021

Edith J Ross, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-2290    Fax: 814-643-8334

A Keith Sutton, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1225 Warm Springs Ave, Huntingdon, PA 16652 Phone: 814-643-8556    Fax: 814-643-8490

News Archive

Two middle school students join scientists to research on key bacterial enzyme

Grown-ups aren't the only ones making exciting scientific discoveries these days. Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. Their study appears in ACS' weekly journal Biochemistry.

Study suggests potential therapy option for early-stage breast cancer

Radionuclide therapy has proven successful in delaying the growth of disseminated tumor cells (DTCs) in early-stage breast cancer in a small animal model, suggesting its use as a potential adjuvant therapy for retarding the proliferation of DTCs.

Positive results from Genentech's T-DM1 Phase III trial on HER2-positive mBC

ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology, today announced that Roche has announced positive topline results from its trastuzumab emtansine (T-DM1) EMILIA Phase III trial.

Psilocybin reduces anxiety, improves mood with advanced-stage cancer: Study

In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety, according to an article published online today in the Archives of General Psychiatry.

CIHR and CH.I.L.D. create Canadian Children Inflammatory Bowel Disease Network

Dr. Grace McCarthy, Chairman of the Board of The Foundation for Children with Intestinal and Liver Disorders (CH.I.L.D), today announced an important new partnership with the Canadian Institutes of Health Research (CIHR) to fund the creation of the Canadian Children Inflammatory Bowel Disease Network: A Joint Partnership of CIHR and the CH.I.L.D. Foundation.

Read more Medical News

› Verified 8 days ago